FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP)
about
Rome Consensus Conference - statement; human papilloma virus diseases in malesHPV vaccination's second act: promotion, competition, and compulsionThe role of HPV in head and neck cancer and review of the HPV vaccineImpact of a physician recommendationHuman papillomavirus vaccination: a case study in translational scienceDiscussing the diagnosis of HPV-OSCC: common questions and answersLessons learned from next-generation sequencing in head and neck cancerHPV related diseases in males: a heavy vaccine-preventable burdenHuman papillomavirus vaccination guideline update: American Cancer Society guideline endorsementDesigning messages to motivate parents to get their preteenage sons vaccinated against human papillomavirus.Development and initial feedback about a human papillomavirus (HPV) vaccine comic book for adolescents.Discussions of adolescent sexuality in news media coverage of the HPV vaccine.Knowledge and beliefs regarding human papillomavirus among college nursing students at a minority-serving institutionHPV vaccine for adolescent males: acceptability to parents post-vaccine licensure.Sources of HPV vaccine hesitancy in parentsMiddle- and high-school health education regarding adolescent vaccines and human papillomavirus.Vaccination in elite athletes.Guillain-Barre syndrome following quadrivalent human papillomavirus vaccination among vaccine-eligible individuals in the United States.Physicians' human papillomavirus vaccine recommendations in the context of permissive guidelines for male patients: a national study.Meta-analysis of human papillomavirus infection concordance.Human papillomavirus vaccine acceptance among young men in Bangalore, IndiaParent-son decision-making about human papillomavirus vaccination: a qualitative analysisHuman papillomavirus infection in a male population attending a sexually transmitted infection service.HPV vaccine hesitancy: findings from a statewide survey of health care providersEffect of decision support on missed opportunities for human papillomavirus vaccinationCorrelates of HPV knowledge among low-income minority mothers with a child 9-17 years of age.Correlates of human papillomavirus vaccine coverage: a state-level analysisEthnic and racial differences in HPV knowledge and vaccine intentions among men receiving HPV test results.Human papillomavirus vaccination for boysA retrospective analysis of the costs and management of genital warts in Italy.Serum antibody response following genital {alpha}9 human papillomavirus infection in young menEarly adoption of the human papillomavirus vaccine among Hispanic adolescent males in the United StatesHPV vaccine and adolescent males.Global challenges of implementing human papillomavirus vaccines.Prevention of anal condyloma with quadrivalent human papillomavirus vaccination of older men who have sex with men.Updates in vaccination: recommendations for adult inflammatory bowel disease patients.The prevalence of genital HPV and factors associated with oncogenic HPV among men having sex with men and men having sex with women and men: the HIM studyHuman papillomavirus (HPV): college male's knowledge, perceived risk, sources of information, vaccine barriers and communication.Promotora Outreach, Education and Navigation Support for HPV Vaccination to Hispanic Women with Unvaccinated DaughtersMultiple human papillomavirus infections and type competition in men
P2860
Q21257274-B85C6443-89A4-4F56-B9CD-F3632EFB9750Q24612957-B51E3814-0262-49FA-8940-BFB86DF158B0Q24630128-34480D8D-235A-4A38-9618-8CB9670AB470Q26779507-72EDC60A-94C4-42F5-B44F-284002E390B8Q26853556-9155B32F-DB52-46F9-933A-78AB3583D884Q27000693-4FCC29D9-5A06-4406-A864-9CA591B892A2Q27009209-B53EF9A6-365C-4773-BBCC-F56D73A9D7EBQ27010120-F04799DC-7E72-4329-9BDD-74DEBC665096Q28069669-F34FE8BE-9803-485B-AA5F-980D6AEF4A90Q30510979-88A7248A-B854-495C-A63E-3C51CE0C2A14Q33645571-DD952D5C-79B0-4DDD-AC7A-C9AFF2401939Q33806585-07A8EE10-1259-4C0C-8483-989468B5D159Q33883221-DDE3B329-CE01-4F31-A5BA-C65632809557Q34097592-78268566-8F2F-42A8-BA5E-4F6E1E327B83Q34170137-2DF1057C-A749-4D8B-AA24-E51EA792A689Q34197043-CF39B199-8694-4B72-8623-51113A35572EQ34227424-F2C48269-BC71-42B0-9C38-97A1FF559313Q34271547-2697DF90-2D77-45C6-BEB4-7019E995DDE1Q34288129-280AD1BC-9E78-43A9-ADF0-2DCC2FC24F04Q34293114-1634DA68-BA83-4556-8086-78B9BC8561C9Q34381178-0C11556D-9556-42C7-BF27-1FAA53A6EA4CQ34513098-0F916FDB-9121-44D0-893D-B5EDB7CDC8C7Q34571148-4FE1460A-BD1C-4341-8544-36A4F788FB45Q34622513-7AC2F85D-7F40-43CD-8505-6138FA688540Q34624814-1EAD06D4-1636-45D1-80FE-66AF463C25B2Q34810247-C8CFF772-D3F1-42D7-BBE1-DD41B49D588EQ34970962-E9EEA060-4FAE-48B7-9A7F-02A1ACEF7A64Q34975418-B0FC716F-453E-46EE-BB21-9AB83C0686B1Q34994792-F13DB7A8-2046-4AB2-AD18-03E42112DD8DQ35012491-73D3BD99-79A3-469E-ABAB-6F9AEF196E3AQ35043684-9ABB3B70-8185-4CA0-84A3-2B9E0936B992Q35062151-EF61B5D0-CA01-45D6-AAE7-69B48A699347Q35126885-A9A60CC1-595B-4CD6-AE38-D89A8D30C6B4Q35128768-1EA0C7C7-0C70-4D00-BA53-63D0F9E4AAD2Q35143152-D1E63E9D-5871-4158-B6ED-664AF58BCE4AQ35188575-03B050EB-7D8C-4251-BAB2-2E1A6FB7BC59Q35226408-BA7DA903-D3FD-44DF-86A9-781835E24E1DQ35234855-D09B11E1-1736-460E-8C61-C9836555012AQ35251971-00D8EF04-CFEC-48F4-B7EA-5F9BA08604E0Q35623752-1D310CEC-1789-48D6-BB5C-9EDE896CCD38
P2860
FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP)
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
FDA licensure of quadrivalent ...... Immunization Practices (ACIP)
@ast
FDA licensure of quadrivalent ...... Immunization Practices (ACIP)
@en
FDA licensure of quadrivalent ...... Immunization Practices (ACIP)
@nl
type
label
FDA licensure of quadrivalent ...... Immunization Practices (ACIP)
@ast
FDA licensure of quadrivalent ...... Immunization Practices (ACIP)
@en
FDA licensure of quadrivalent ...... Immunization Practices (ACIP)
@nl
prefLabel
FDA licensure of quadrivalent ...... Immunization Practices (ACIP)
@ast
FDA licensure of quadrivalent ...... Immunization Practices (ACIP)
@en
FDA licensure of quadrivalent ...... Immunization Practices (ACIP)
@nl
P1476
FDA licensure of quadrivalent ...... Immunization Practices (ACIP)
@en
P304
P407
P577
2010-05-01T00:00:00Z